Document Detail


Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.
MedLine Citation:
PMID:  2866266     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The venodilating action of nipradilol was investigated by monitoring arterial blood pressure (BP), cardiac output (CO), heart rate (HR) and central venous pressure (CVP) in pithed rats treated with dihydroergotamine (DHE). DHE increased CVP and produced a simultaneous rise in BP and CO without appreciable changes in total peripheral resistance (TPR) and HR, indicating that DHE reduces venous capacity through venoconstriction. Nipradilol caused a fall in CVP, BP and CO without changing the TPR in the DHE-pretreated rat. By comparison, hydralazine reduced BP and TPR without changes in CO. Propranolol produced only a transient decrease in BP and TPR. These results indicate that nipradilol dilates venous capacitance vessels and thereby decreases cardiac filling pressure in animals with high venous tone, whereas hydralazine preferentially dilates resistance vessels.
Authors:
Y Shirasawa; M Fujii; M Nakamura
Related Documents :
19099326 - Manual assessment of the initial fall in blood pressure after orthostatic challenge at ...
19074806 - Impact of systemic blood pressure on the relationship between intraocular pressure and ...
17392676 - Child with fulminant myocarditis survived by ecmo support--report of a child case.
6487416 - Effects of drug-induced changes in resting blood pressure on classically conditioned he...
20436036 - Cardiac resynchronization therapy for the causal treatment of heart failure with preser...
9845406 - Effects of somatostatin on proximal gastric motor function and visceral perception.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Japanese journal of pharmacology     Volume:  39     ISSN:  0021-5198     ISO Abbreviation:  Jpn. J. Pharmacol.     Publication Date:  1985 Sep 
Date Detail:
Created Date:  1986-01-15     Completed Date:  1986-01-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2983305R     Medline TA:  Jpn J Pharmacol     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  77-82     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / pharmacology*
Animals
Decerebrate State
Dihydroergotamine / pharmacology*
Hemodynamics / drug effects*
Hydralazine / pharmacology
Male
Propanolamines / pharmacology*
Propranolol / pharmacology
Rats
Rats, Inbred Strains
Time Factors
Vasodilator Agents / pharmacology*
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Propanolamines; 0/Vasodilator Agents; 511-12-6/Dihydroergotamine; 525-66-6/Propranolol; 81486-22-8/K 351; 86-54-4/Hydralazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Changes in 3H-spiperone, 3H-WB 4101 and 3H-dihydroalprenolol bindings to brain membranes produced by...
Next Document:  Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the est...